Hot off the Press: LOw dose MAGnesium sulfate versus HIgh dose in the early management of rapid atrial fibrillation: randomised controlled double‐blind study

Abstract

Atrial fibrillation is the most common cardiac dysthrymia. Several rate‐control strategies have been used, and magnesium sulfate has been investigated as an adjunct. In this review, we look at a trial by Bouida et al in which magnesium sulfate was studied in two different doses for rate control in atrial fibrillation. In addition, we review the social media commentary in response to the Skeptics Guide of Emergency Medicine Hot of the Press podcast.

This article is protected by copyright. All rights reserved.

https://ift.tt/2SwpeoO